April McClain Delaney
April McClain Delaney (D-MD) sold $1K-$15K of $TECH (Bio-Techne Corp - Common Stock) on Jan 28, 2026, part of 15 transactions in this filing (1 buys, 14 sells).
HillSignal flagged 5 timing concerns on this filing — trades that line up closely with related legislative or contract activity.
Companies in this filing · 10
Price Movement Since Trade
How the largest positions have moved from the trade date to the most recent close.
Showing the 6 largest positions. See every transaction in the table below.
Suspicious Timing Detected
5 flagsRep. McClain Delaney bought $1,001 - $15,000 in $LH on 2026-01-28, 15 days before the Veterans Community Care Scheduling Improvement Act (HR3482) was introduced, which mandates the VA to establish an online system for scheduling veteran appointments.
Rep. McClain Delaney bought $1,001 - $15,000 in $LH on 2026-01-28, 35 days before HR7787 was introduced, a bill establishing a mental health provider loan deferment and forgiveness program.
Rep. McClain Delaney bought $1,001 - $15,000 in $LH on 2026-01-28, 40 days before HR7868 was introduced, a bill that increases financial incentives for living organ donation.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | $LH | Labcorp Holdings Inc. Common Stock | $1K-$15K | — | $254.26 | — | Jan 28, 2026 |
| PARTIAL SELL | $TECH | Bio-Techne Corp - Common Stock | $1K-$15K | $65.56 | $45.24 | -31.0% | Jan 28, 2026 |
| PARTIAL SELL | $BJ | BJ's Wholesale Club Holdings, Inc. Common Stock | $1K-$15K | $91.58 | $95.39 | +4.2% | Jan 28, 2026 |
| SELL | $IDXX | IDEXX Laboratories, Inc. - Common Stock | $1K-$15K | $714.04 | $546.36 | -23.5% | Jan 13, 2026 |
| PARTIAL SELL | $MORN | Morningstar, Inc. - Common Stock | $1K-$15K | $215.64 | $169.06 | -21.6% | Jan 15, 2026 |
| PARTIAL SELL | $PTC | PTC Inc. - Common Stock | $1K-$15K | $162.14 | $144.63 | -10.8% | Jan 23, 2026 |
| SELL | $PTC | PTC Inc. - Common Stock | $1K-$15K | $162.14 | $144.63 | -10.8% | Jan 30, 2026 |
| PARTIAL SELL | $SGI | Somnigroup International Inc. Common Stock | $1K-$15K | — | $62.00 | — | Jan 12, 2026 |
| PARTIAL SELL | $SGI | Somnigroup International Inc. Common Stock | $1K-$15K | — | $62.00 | — | Jan 22, 2026 |
| PARTIAL SELL | $TRMB | Trimble Inc. - Common Stock | $1K-$15K | $68.37 | $53.98 | -21.0% | Jan 29, 2026 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
Medical Nutrition Therapy Act of 2026
The Medical Nutrition Therapy Act of 2026 structurally expands Medicare Part B to cover nutrition counseling for obesity, cancer, HIV/AIDS, and eating disorders — a direct benefit expansion for MA insurers Humana, UnitedHealth, Centene, and CVS Health, which can integrate these services to manage chronic disease costs. The bill is early-stage (referred to Senate Finance, 2 co-sponsors), but real market data shows the affected tickers have experienced 19-70% 30-day gains, reflecting broader sector momentum.
Railway Safety Act of 2026
The Railway Safety Act of 2026 (HR7748), referred to two House committees, mandates enhanced tank car safety, defect detection systems, and ECP braking for high-hazard trains. This creates a procurement tailwind for railcar manufacturers ($GBX, $TRN) and safety tech providers ($WAB), while imposing significant compliance costs on Class I railroads ($UNP, $CSX, $NSC). The bill is in early legislative stages with a companion bill in the Senate.
Snow Water Supply Forecasting Reauthorization Act of 2025
The Snow Water Supply Forecasting Reauthorization Act is a low-impact authorization bill with no specified funding. It creates a favorable procurement framework for Trimble's lidar and spectroscopy systems, but actual market impact is negligible until appropriations are passed. $TRMB trades at $67, down 3.5% over the past week, within its 52-week range of $62-$87.5.
Veterans Community Care Scheduling Improvement Act
HR3482 is a procedural authorization bill requiring the VA to build an online scheduling system for community care appointments. It mandates an IT system change but includes no explicit funding, and it does not directly increase patient volume or reimbursement rates. The market impact on healthcare stocks ($DGX, $LH, $HCA, $UHS, $AMN) is negligible in the near term.
Emergency Medical Services Reimbursement for On-Scene and Support Act
HR7277 is an early-stage bill that would allow Medicare to reimburse ambulance services for on-scene treatment without transport. The bill has 8 cosponsors, no explicit funding authorization, and a long legislative path ahead. No direct near-term market impact on publicly traded companies is identifiable from this legislation alone.
Rural Health Care Facilities Revitalization Act
HR7514 is an early-stage bill with no funding authorized and no path to passage evident — 3 cosponsors, referred to committee on introduction date only. Real market data shows $GEHC down -15.58% over 30 days and $TDOC flat at +0.37%. The market is correctly not pricing in any impact from this bill. No actionable trade signal exists.
PETSAFE Act of 2026
The PETSAFE Act (HR7438) is an early-stage bill authorizing a higher federal cost share (90% vs 50%) for state and local emergency preparedness activities benefiting companion animals. It lists eligible purchases including crates, veterinary supplies, and disaster response software. However, the bill is only an authorization—no funds are appropriated—and it remains in committee with limited legislative momentum. Market impact is minimal and speculative for pet-related product and service providers.
To amend title VII of the Public Health Service Act to strengthen the mental health workforce, and for other purposes.
HR7787 is an early-stage bill authorizing a mental health provider loan forgiveness program. It has been referred to committee with no companion bill, zero appropriations, and minimal legislative momentum. Market impact is negligible at this stage. Real market data shows AMN Healthcare at $20.65, up 12.6% over 30 days, and Centene at $53.22, up 62.55% over 30 days, driven by other factors unrelated to this procedural bill.
To amend the Public Health Service Act with respect to the Living Organ Donation Reimbursement Program.
HR7868, the 'Expanding Support for Living Donors Act of 2026,' is an early-stage bill authorizing up to $10,000 per donor for qualifying expenses in FY2027. Actual appropriations are required. The market reaction in diagnostic ($LH, $DGX) and device ($MDT, $SYK) stocks is currently driven by broader market trends — all four stocks are down 2-9% over the past 30 days — not by this bill's introduction. The legislative impact on revenue is negligible at this stage.
Expanded Telehealth Access Act
The Expanded Telehealth Access Act (S.3834) is an early-stage Senate bill that permanently adds audiologists, physical therapists, occupational therapists, speech-language pathologists, and assistants to Medicare telehealth eligibility. No funding is authorized. Market data shows mixed conviction: TDOC down 4.87% in the last 7 days to $5.47, while AMWL gained 3.06% to $6.06, indicating no material premium is priced in for this low-probability legislative event.
Other Filings by April McClain Delaney
Free — no credit card
Get the next Delaney trade the day it's disclosed
HillSignal tracks every Congressional stock filing and federal contract, scores its market impact with AI, and emails you the ones that matter — before they hit the news.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.